SEC Filing Summary: Intrexon Corporation (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Intrexon Corporation on January 17, 2018, with the earliest event reported on the same date. The filing details the entry into a material definitive agreement for an underwritten public offering of common stock. Note: While the request metadata references "PRECIGEN, INC.", the filing text explicitly identifies the registrant as Intrexon Corporation.
Key Financial Metrics and Transaction Details
- Offering Structure: Issuance of 6,000,000 firm shares plus a fully exercised option for 900,000 additional shares (6,900,000 total shares).
- Public Offering Price: $12.50 per share.
- Net Proceeds: Approximately $82 million after deducting underwriting discounts and estimated offering expenses.
- Related Party Transaction: Entities affiliated with Chairman and CEO Randal J. Kirk purchased 1,000,000 shares at the public offering price of $12.50 per share (no underwriting discount applied to these shares).
- Underwriting Discount: $0.625 per share on non-related party shares, resulting in a net price to the company of $11.875 per share for those shares.
- Closing Date: January 19, 2018.
Material Changes
The filing reports a significant capital raise event. The company increased its equity capital by issuing 6.9 million shares. The filing does not provide comparative financial metrics (revenue, profit, cash flow, or debt levels) for the prior period as this is a transaction-specific report rather than a periodic financial statement.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond standard underwriting agreement indemnities. The primary contingency noted is the customary indemnification of underwriters against liabilities under the Securities Act of 1933.
Investor Verification Checklist
- Verify the total number of shares outstanding post-offering to assess dilution impact.
- Confirm the specific use of the approximately $82 million in net proceeds as disclosed in the final prospectus supplement.
- Review the full Underwriting Agreement (Exhibit 1.1) for lock-up periods and specific covenants.
- Validate the extent of the related party purchase by Randal J. Kirk's affiliated entities.